Europe Venture Capital Report 2021 — A Record Year on Borrowed Capital

European venture funding reached a record in 2021 by every measure — total capital, round sizes, number of large rounds, and the count of companies valued above a billion euros.

The composition of that record is what matters, and it is the difference between a structural improvement and a temporary condition.

A large share of the capital came from outside Europe: US venture and growth funds, crossover investors, sovereign vehicles and corporate investors. Their participation reflected conditions described in the Global Investment Outlook 2021 and the US Venture Capital Report 2021 — abundant capital, near-zero rates, and a competitive environment in their home markets that made access rather than selection the binding constraint.

When access is the constraint, expanding the geography is a rational response. An investor unable to win competitive rounds at home can find less-competed opportunities elsewhere, and Europe offered good companies at historically lower valuations.

So the capital arrived for reasons that were about the investors' home markets, not about Europe. That distinction is the whole report, because it determines what happens when those conditions change — which the 2023 report describes.

Three consequences followed.

The growth-stage gap appeared to close. Large rounds happened. But they were led from outside, which means the domestic capacity the 2019 report identifies as the actual constraint did not develop. The gap was filled, not closed.

Entry prices rose sharply, eroding the valuation advantage that had been a significant part of the case for European investment.

The recycling loop genuinely improved, as more companies reached scale and more employees held valuable equity. This is the year's durable gain and it is real.

What imported capital is and is not

The distinction between imported and domestic capital is not about the investors' nationality. It is about what determines their participation.

Domestic capital's participation depends on domestic conditions. A European fund raised from European institutions deploys into Europe because that is its mandate. Its capacity depends on European fundraising, which depends on European LP appetite, which depends on European returns and exit conditions.

Imported capital's participation depends on conditions in its home market. A US growth fund investing in Europe does so because the risk-adjusted opportunity looks better than its domestic alternatives at that moment. When domestic alternatives improve — or when its own capital becomes constrained — the calculus changes for reasons with no European content.

The consequences of the distinction:

• Imported capital is more volatile, because it responds to a variable the destination market does not control.
• It is most abundant when it is least needed — in periods of global abundance, when domestic capital is also easier to raise — and scarcest when it would be most valuable.
• It does not build local capacity. A round led by a foreign investor does not produce a domestic growth track record, so the domestic funds that would provide stability still cannot be raised.
• It is not a criticism of the investors. They are behaving rationally and providing genuine value. The point is about what the destination market can rely on.

Capital that arrives because of conditions elsewhere leaves because of conditions elsewhere. That is not disloyalty — it is what the capital is. The error is treating its presence as evidence that a structural problem has been solved.

This is the same dynamic the India Venture Capital Report 2021 describes, where capital reallocated from another Asian market inflated Indian valuations for reasons unrelated to Indian fundamentals. The mechanism is identical and so is the consequence: a vintage that entered at prices set by external conditions.

Why the gap was filled rather than closed

The distinction between filling a gap and closing it is precise and consequential.

Closing the gap would mean European institutions allocating to European growth funds at a scale that makes large domestic rounds routinely possible. That requires change in the LP chain the 2019 report describes: pension structure, insurer regulatory capital treatment, and exit market depth.

Filling the gap means the rounds happen, led by someone else. The companies get funded — which is genuinely good for those companies — and none of the underlying constraints change.

What 2021 did:

• Large rounds happened at unprecedented scale. Real, and good for the companies involved.
• European LP allocation to venture did not materially change. Pension structure was unchanged. Insurance capital treatment was unchanged. The reasons European institutions were under-allocated remained.
• Few new large European growth funds were raised, because the rounds were being led by others and because a manager still could not point to a European growth track record.
• So the structure was identical at the end of the year to the start, with better numbers on top of it.

Why filling can be worse than not filling, in one specific respect: a filled gap looks solved. Attention and policy urgency move elsewhere. The capital markets reform agenda that would address the actual constraint becomes less pressing when the headline numbers are strong.

That is the sense in which 2021 deferred the problem. The 2023 report describes the imported capital withdrawing and the gap reappearing exactly where the 2019 report said it would — with two years having passed and nothing structural having changed.

The valuation advantage disappears

A significant part of the historical case for European venture was price, and 2021 largely removed it.

The historical position. European companies at a given stage and quality raised at lower valuations than US equivalents. The discount reflected real factors: thinner competition among investors, a weaker exit market reducing achievable returns, and smaller addressable domestic markets.

Why the discount mattered to returns. As the US Venture Capital Report 2021 establishes, entry price is the dominant determinant of venture returns and it is fixed at the decision point. A market where equivalent companies could be bought for less produced better returns on identical operating performance.

What 2021 did to it. Competition from imported capital bid prices up. The investors arriving were accustomed to US valuations and were competing on speed and price to win access — the exact dynamic the US Venture Capital Report 2021 describes. European valuations converged toward US levels at the stages where imported capital was most active.

Why the convergence was not obviously justified:

• The exit market had not improved correspondingly. Achievable exit valuations still reflected thinner public markets and a smaller acquirer population.
• The fragmentation cost was unchanged, so the path to scale was still longer and the achievable margin lower.
• The addressable domestic market was unchanged.

So entry prices converged while exit prospects did not, which compresses the return on the intervening work. That is the arithmetic of the 2021 European vintage, and it is the same arithmetic as the US 2021 vintage with an additional structural handicap.

The recycling loop genuinely improved

Against the caveats above, one gain from 2021 is real and durable, and it deserves equal weight.

What happened. More European companies reached significant scale. More employees held equity that became valuable. More founders experienced building a company past the point where scaling problems appear. A cohort of operators with genuine scale experience was created.

Why this is the durable gain, per the framework the 2017 report establishes: an ecosystem's scarce input is density — the population of people who have done it before and will fund and advise those doing it now. Capital can be imported; density cannot.

The specific improvements:

• Operator density rose at the senior levels where Europe had been thinnest. Executives who have scaled an organisation from two hundred to two thousand people were previously rare in most European ecosystems.
• Angel capacity grew, as employees realised equity value.
• The founder pipeline improved, since people who have worked in a company that scaled are disproportionately likely to found one.
• The knowledge is local and stays local, unlike the capital.

The caveat is the one the 2019 report identifies. Companies sold early produce smaller proceeds pools and fewer people who have experienced full scaling. The recycling gain from 2021 depends on how those companies eventually exit — and a cohort that raised at 2021 prices and exits at lower valuations recycles less than the funding totals suggested at the time.

The honest assessment is that the density gain is real and partially banked, and its full extent depends on outcomes that were still unresolved when this report was written.

The crowding-out that mattered most

An effect of 2021 that received almost no attention was the one with the longest consequences: imported capital competed with the domestic capacity that was trying to form.

The situation for a European growth fund raising in 2021. A first-time or second-time European growth manager was attempting to raise from institutions who were being told, correctly, that European growth rounds were being led at scale by established American funds with long records.

The pitch that manager had to make was: commit to me rather than gaining exposure through an established manager who is already deploying here successfully. That is a difficult argument in any market and it was close to impossible in one where the alternative was visibly abundant.

The consequences:

• European growth funds raised smaller vehicles than they otherwise might have, or did not raise at all.
• The track record problem the 2019 report identifies was made worse. A manager who cannot raise cannot deploy, cannot generate a record, and cannot raise a larger successor fund. The window in which capital was most abundant was the window in which building that record was hardest.
• LPs who might have taken a first-time European growth manager had an easier alternative, which is a rational choice at the individual level and a poor one at the system level.

This is a coordination problem of the kind the Global Investment Outlook 2021 describes: each participant behaves sensibly, and the aggregate outcome is worse than any of them intended. The European LP choosing an established US manager over an unproven European one is making a defensible decision. The aggregate effect is that domestic capacity does not form during the only period when the capital to form it was available.

The timing is what makes it costly. Domestic growth capacity was most fundable in 2021, when institutional appetite for the asset class was highest. The moment of maximum capital availability was the moment of maximum competitive disadvantage for the funds that needed to be built — and by the time the imported capital withdrew in 2023, the fundraising environment had closed for everyone.

What an allocator could act on

Ask what determines a capital source's participation. Domestic capital responds to domestic conditions; imported capital responds to conditions in its home market. A market whose growth funding is imported has outsourced its most important stage to a variable it does not control.

Distinguish a filled gap from a closed one. The test is whether the structural constraint changed. If European LP allocation, insurer capital treatment and exit market depth are unchanged, the gap is filled and remains conditional regardless of the headline numbers.

Check whether entry price convergence was matched by exit prospect convergence. European valuations converged toward US levels in 2021 while the exit market did not. That compresses returns on identical operating performance, and it is computable rather than a matter of opinion.

Watch European LP allocation, not funding totals. Invest Europe breaks out LP type free and annually. A rise in pension and insurer commitments to European venture is the signal that the structure is changing; a rise in funding totals is not.

Value the density gain separately from the capital. Operator experience is local and durable where capital is not. It is the year's genuine structural improvement and it is not visible in any funding statistic.

Model the European 2021 vintage with the additional handicap. It carries the same entry-price problem as the US 2021 vintage plus an unchanged fragmentation cost and a thinner exit market. Applying US vintage assumptions to it understates the difficulty.

What 2021 established for Europe

• A record funding year was shown to be composed of imported capital, whose participation depended on conditions elsewhere.
• The distinction between filling and closing a gap was demonstrated, along with the risk that a filled gap reduces the urgency of addressing the structural cause.
• Entry price convergence without exit prospect convergence compressed the return on the European vintage specifically.
• The recycling loop improved genuinely, producing the operator density that is an ecosystem's scarce and local input.
• Domestic capacity did not develop, because rounds led from outside build no domestic track record.